Premium
Non‐alcoholic fatty liver disease: Further expression of the metabolic syndrome
Author(s) -
Tarantino Giovanni,
Saldalamacchia Gennaro,
Conca Paolo,
Arena Adriano
Publication year - 2007
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2007.04824.x
Subject(s) - medicine , fatty liver , metabolic syndrome , alcoholic liver disease , disease , gastroenterology , obesity , cirrhosis
Non‐alcoholic fatty liver disease has been associated with metabolic disorders, including central obesity, dyslipidema, hypertension and hyperglycemia. Metabolic syndrome, obesity, and insulin resistance are major risk factors in the pathogenesis of non‐alcoholic fatty liver disease. Non‐alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non‐alcoholic steatohepatitis, advanced fibrosis and cirrhosis.